Smaller-Incision new-generation implantable miniature telescope: Three-months follow-up study.
Eur J Ophthalmol
; : 11206721231212545, 2023 Nov 03.
Article
in En
| MEDLINE
| ID: mdl-37920982
ABSTRACT
PURPOSE:
To evaluate three months follow-up of SING IMT implant in patients affected by late-stage AMD.DESIGN:
Prospective cohort study.SUBJECTS:
In a total of 80 eyes of 40 patients who underwent the enrollment tests, 11 patients' eyes affected by late-stage AMD matched the inclusion criteria and underwent SING IMT implant from February to June 2022.METHODS:
Before surgery, each patient underwent the enrollment examination to verify inclusion and exclusion criteria. MAIN OUTCOMEMEASURES:
BCVA for distance and for near, IOP, ACD and ECD were evaluated at 1 and 3 months follow up. Also quality of life in doing the activities of daily life was evaluated.RESULTS:
BCVA for distance and for near improved from baseline to 3 months follow up (23.91 ± 9.418 ETDRS letters and 59.09 ± 11.58 ETDRS letters respectively (p < 0.001). An endothelial cell loss was shown (p < 0.001), with a rate of cell density reduction around 8.3% (baseline vs 3 months).CONCLUSIONS:
SING IMT could be a valid surgical device to improve patients' sight and quality of life which have been deteriorated by late-stage macular degeneration. Further studies with more patients and longer follow up are needed to confirm our results.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Eur J Ophthalmol
Journal subject:
OFTALMOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Italy
Publication country:
EEUU
/
ESTADOS UNIDOS
/
ESTADOS UNIDOS DA AMERICA
/
EUA
/
UNITED STATES
/
UNITED STATES OF AMERICA
/
US
/
USA